Securities code: 300006 securities abbreviation: Chongqing Lummy Pharmaceutical Co.Ltd(300006) Announcement No.: 2021 – 083 Chongqing Lummy Pharmaceutical Co.Ltd(300006)
Announcement on resolutions of the 17th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as “the company”) issued a notice on convening the 17th meeting of the Fifth Board of supervisors to the supervisors on December 9, 2021, and the meeting was held on December 14, 2021 (Tuesday) at 16:00, the meeting was held in the conference room on the 13th floor of the company’s headquarters by means of communication voting. There were 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The number of supervisors attending the meeting met the provisions of the law and the articles of Association. The meeting was presided over by Ms. yuan yuan, chairman of the company’s board of supervisors. After deliberation and written voting by the attending supervisors, the following proposals were considered and adopted:
1. The proposal on nominating Ms. Tan Mingyue as a candidate for non employee representative supervisor of the Fifth Board of supervisors of the company was deliberated and adopted
The board of supervisors of the company received the written resignation report of Ms. Chen Feng, the supervisor of the company, on November 16, 2021. Ms. Chen Feng applied for resignation as a non employee representative supervisor of the board of supervisors of the company for personal reasons. After resignation, Ms. Chen Feng will no longer hold any position in the company. After extensive consultation in accordance with the company law of the people’s Republic of China and the articles of association, The board of supervisors of the company recommends Ms. Tan Mingyue as a candidate for non employee representative supervisor of the Fifth Board of supervisors of the company. The term of office starts from the date of adoption by the general meeting of shareholders of the company to the expiration of the term of office of the current board of supervisors.
Voting results: 3 in favor, 0 against and 0 abstention.
For details, see the announcement on the company’s change of non employee representative supervisors issued by the gem information disclosure website designated by the CSRC.
This proposal needs to be submitted to the general meeting of shareholders for deliberation.
It is hereby announced.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) board of supervisors December 14, 2021
